Abstract
Glycogen synthase kinase 3β (GSK-3β) can modulate myofilament function in vitro. However, it’s in vivo role, mechanism, and translational relevance are unknown, which we investigated using inducible cardiomyocyte-specific GSK-3β KO mice. Compared to tamoxifen-treated GSK-3βfl/fl/Cre-mice (Con), skinned myocytes from KO mice had reduced calcium sensitivity at long sarcomere lengths (SL = 2.2 μm), but there were no differences at short SL (∼1.9 μm). Thus, myocytes from KO mice did not sensitize to calcium with stretch, a mechanism called length dependent activation (LDA) underlying the organ-level Frank-Starling law.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have